NewGenIvf Group Ltd is a SG-based company operating in Health Care Providers & Services industry. The company employs 76 full-time employees The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy (MRT) In Reproductive, Intrauterine Insemination (IUI), MRT techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular/epididymal sperm aspiration or extraction/percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening, and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The Company’s subsidiary is NewGenIvf Limited.
Follow-Up Questions
Qui est le CEO de NewGenIvf Group Ltd ?
Mr. Claudius Tsang est le Chairman of the Board de NewGenIvf Group Ltd, il a rejoint l'entreprise depuis 2021.
Quelle est la performance du prix de l'action NIVF ?
Le prix actuel de NIVF est de $0.6385, il a increased de 0.7% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de NewGenIvf Group Ltd ?
NewGenIvf Group Ltd appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de NewGenIvf Group Ltd ?
La capitalisation boursière actuelle de NewGenIvf Group Ltd est de $1.1M
